Concepts (308)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Splenectomy | 3 | 2025 | 61 | 1.740 |
Why?
|
| Surgeons | 6 | 2026 | 288 | 1.650 |
Why?
|
| Internship and Residency | 11 | 2026 | 1219 | 1.650 |
Why?
|
| Vascular Malformations | 3 | 2025 | 103 | 1.600 |
Why?
|
| Lymphatic Abnormalities | 5 | 2024 | 35 | 1.350 |
Why?
|
| Hemangioma | 6 | 2025 | 87 | 1.300 |
Why?
|
| Spleen | 2 | 2025 | 257 | 1.250 |
Why?
|
| Anorectal Malformations | 2 | 2025 | 17 | 1.090 |
Why?
|
| Burnout, Professional | 5 | 2021 | 134 | 1.080 |
Why?
|
| Education, Medical, Graduate | 6 | 2020 | 552 | 1.000 |
Why?
|
| Splenic Vein | 1 | 2025 | 10 | 0.890 |
Why?
|
| Splenic Artery | 1 | 2025 | 22 | 0.880 |
Why?
|
| Sirolimus | 3 | 2024 | 231 | 0.880 |
Why?
|
| Biliary Dyskinesia | 1 | 2024 | 5 | 0.860 |
Why?
|
| Cholecystectomy | 1 | 2024 | 57 | 0.830 |
Why?
|
| Depression, Postpartum | 1 | 2023 | 52 | 0.770 |
Why?
|
| Hirschsprung Disease | 4 | 2024 | 38 | 0.710 |
Why?
|
| Postoperative Complications | 9 | 2026 | 3120 | 0.680 |
Why?
|
| Infant | 25 | 2026 | 13239 | 0.660 |
Why?
|
| Colectomy | 3 | 2024 | 89 | 0.620 |
Why?
|
| Colitis, Ulcerative | 2 | 2023 | 208 | 0.610 |
Why?
|
| Child | 33 | 2026 | 26097 | 0.610 |
Why?
|
| Registries | 4 | 2025 | 1609 | 0.590 |
Why?
|
| Ovarian Cysts | 1 | 2019 | 20 | 0.580 |
Why?
|
| Sclerotherapy | 4 | 2024 | 36 | 0.550 |
Why?
|
| Leadership | 1 | 2020 | 244 | 0.550 |
Why?
|
| Hospital Mortality | 4 | 2026 | 1059 | 0.540 |
Why?
|
| Ileostomy | 1 | 2018 | 30 | 0.540 |
Why?
|
| Liver Neoplasms | 3 | 2025 | 1362 | 0.530 |
Why?
|
| General Surgery | 2 | 2026 | 225 | 0.520 |
Why?
|
| Interpersonal Relations | 1 | 2019 | 222 | 0.520 |
Why?
|
| Humans | 63 | 2026 | 130342 | 0.510 |
Why?
|
| Infant, Newborn | 18 | 2026 | 8532 | 0.510 |
Why?
|
| Ovarian Diseases | 1 | 2016 | 23 | 0.500 |
Why?
|
| Torsion Abnormality | 1 | 2016 | 28 | 0.490 |
Why?
|
| Retrospective Studies | 23 | 2026 | 17516 | 0.480 |
Why?
|
| Embolization, Therapeutic | 2 | 2016 | 225 | 0.480 |
Why?
|
| Hemangioma, Capillary | 1 | 2015 | 20 | 0.450 |
Why?
|
| Leukemia, Myeloid | 1 | 2014 | 80 | 0.430 |
Why?
|
| Kidney Neoplasms | 2 | 2017 | 419 | 0.420 |
Why?
|
| Digestive System Surgical Procedures | 3 | 2026 | 84 | 0.420 |
Why?
|
| Treatment Outcome | 14 | 2025 | 12840 | 0.420 |
Why?
|
| Evidence-Based Medicine | 4 | 2025 | 644 | 0.410 |
Why?
|
| Nephrectomy | 1 | 2015 | 155 | 0.410 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2014 | 125 | 0.400 |
Why?
|
| Myeloproliferative Disorders | 1 | 2014 | 91 | 0.400 |
Why?
|
| Neonatal Screening | 1 | 2015 | 205 | 0.390 |
Why?
|
| Faculty, Medical | 2 | 2026 | 279 | 0.380 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2015 | 222 | 0.380 |
Why?
|
| Adolescent | 16 | 2026 | 20718 | 0.370 |
Why?
|
| Female | 34 | 2026 | 70331 | 0.370 |
Why?
|
| Fecal Incontinence | 2 | 2025 | 76 | 0.360 |
Why?
|
| Databases, Factual | 7 | 2026 | 1223 | 0.350 |
Why?
|
| Constipation | 2 | 2025 | 130 | 0.350 |
Why?
|
| Child, Preschool | 14 | 2025 | 14949 | 0.340 |
Why?
|
| Aptamers, Nucleotide | 1 | 2011 | 37 | 0.340 |
Why?
|
| Hospitals, Pediatric | 3 | 2026 | 798 | 0.330 |
Why?
|
| Male | 32 | 2026 | 64409 | 0.320 |
Why?
|
| Fellowships and Scholarships | 3 | 2023 | 323 | 0.300 |
Why?
|
| Algorithms | 3 | 2025 | 1659 | 0.290 |
Why?
|
| Risk Assessment | 2 | 2015 | 3672 | 0.280 |
Why?
|
| Surveys and Questionnaires | 6 | 2026 | 4027 | 0.280 |
Why?
|
| Skin Neoplasms | 1 | 2015 | 899 | 0.270 |
Why?
|
| Anus, Imperforate | 2 | 2024 | 19 | 0.260 |
Why?
|
| Survival Rate | 4 | 2015 | 2110 | 0.250 |
Why?
|
| United States | 10 | 2026 | 11859 | 0.250 |
Why?
|
| Abnormalities, Multiple | 3 | 2024 | 964 | 0.240 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2024 | 977 | 0.240 |
Why?
|
| Child Care | 1 | 2026 | 12 | 0.240 |
Why?
|
| Sexism | 1 | 2026 | 42 | 0.240 |
Why?
|
| Thoracic Duct | 2 | 2016 | 5 | 0.230 |
Why?
|
| Lymphography | 2 | 2016 | 9 | 0.230 |
Why?
|
| Physicians, Women | 1 | 2026 | 53 | 0.230 |
Why?
|
| Elective Surgical Procedures | 1 | 2026 | 163 | 0.230 |
Why?
|
| Splenic Diseases | 1 | 2025 | 28 | 0.220 |
Why?
|
| Pancreatic Neoplasms | 1 | 2011 | 732 | 0.220 |
Why?
|
| Urinary Incontinence | 1 | 2025 | 68 | 0.210 |
Why?
|
| Gastroschisis | 1 | 2024 | 57 | 0.200 |
Why?
|
| Ultrasonography | 2 | 2019 | 955 | 0.200 |
Why?
|
| Infant, Premature, Diseases | 1 | 2026 | 252 | 0.200 |
Why?
|
| Job Satisfaction | 2 | 2021 | 100 | 0.200 |
Why?
|
| Personal Satisfaction | 2 | 2021 | 104 | 0.200 |
Why?
|
| Colostomy | 1 | 2022 | 29 | 0.190 |
Why?
|
| Neoplasm Staging | 3 | 2015 | 1279 | 0.190 |
Why?
|
| Delphi Technique | 1 | 2024 | 270 | 0.190 |
Why?
|
| Gestational Age | 4 | 2026 | 1213 | 0.190 |
Why?
|
| Reoperation | 2 | 2016 | 818 | 0.180 |
Why?
|
| Accreditation | 2 | 2013 | 85 | 0.180 |
Why?
|
| Enterocolitis | 1 | 2023 | 30 | 0.180 |
Why?
|
| Pneumothorax | 1 | 2023 | 79 | 0.180 |
Why?
|
| Foreign Bodies | 2 | 2020 | 96 | 0.180 |
Why?
|
| Parenting | 1 | 2026 | 346 | 0.180 |
Why?
|
| Incidence | 3 | 2024 | 3316 | 0.180 |
Why?
|
| Venous Thromboembolism | 1 | 2024 | 191 | 0.170 |
Why?
|
| Compassion Fatigue | 1 | 2021 | 10 | 0.170 |
Why?
|
| Neuroblastoma | 2 | 2017 | 543 | 0.170 |
Why?
|
| Appendicitis | 1 | 2022 | 132 | 0.170 |
Why?
|
| Magnets | 1 | 2020 | 22 | 0.160 |
Why?
|
| Hospitals | 1 | 2023 | 437 | 0.160 |
Why?
|
| Lymphangioma | 1 | 2020 | 21 | 0.160 |
Why?
|
| Lymphatic Vessels | 1 | 2020 | 31 | 0.160 |
Why?
|
| Quality of Life | 3 | 2026 | 2081 | 0.160 |
Why?
|
| Enterocolitis, Necrotizing | 2 | 2021 | 256 | 0.160 |
Why?
|
| Down Syndrome | 1 | 2023 | 234 | 0.150 |
Why?
|
| Parental Leave | 1 | 2019 | 4 | 0.150 |
Why?
|
| Harassment, Non-Sexual | 1 | 2019 | 1 | 0.150 |
Why?
|
| Incivility | 1 | 2019 | 2 | 0.150 |
Why?
|
| Medical Errors | 2 | 2021 | 145 | 0.150 |
Why?
|
| Prejudice | 1 | 2019 | 39 | 0.150 |
Why?
|
| Career Choice | 1 | 2020 | 168 | 0.140 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2023 | 323 | 0.140 |
Why?
|
| Conservative Treatment | 1 | 2019 | 46 | 0.140 |
Why?
|
| Organizational Culture | 1 | 2019 | 94 | 0.140 |
Why?
|
| Intestinal Obstruction | 1 | 2019 | 86 | 0.140 |
Why?
|
| Injury Severity Score | 2 | 2016 | 233 | 0.140 |
Why?
|
| Ultrasonography, Doppler | 1 | 2019 | 185 | 0.140 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2015 | 1074 | 0.140 |
Why?
|
| Ontario | 1 | 2018 | 84 | 0.130 |
Why?
|
| Pregnancy | 4 | 2024 | 7418 | 0.130 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 5162 | 0.130 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 3795 | 0.130 |
Why?
|
| Aggression | 1 | 2019 | 218 | 0.130 |
Why?
|
| Shorthand | 1 | 2016 | 1 | 0.130 |
Why?
|
| Vascular Access Devices | 1 | 2017 | 34 | 0.130 |
Why?
|
| Surgical Stomas | 1 | 2016 | 6 | 0.130 |
Why?
|
| Enterostomy | 1 | 2016 | 6 | 0.130 |
Why?
|
| Aircraft | 1 | 2016 | 19 | 0.130 |
Why?
|
| Air Ambulances | 1 | 2016 | 24 | 0.120 |
Why?
|
| Patient Acuity | 1 | 2016 | 66 | 0.120 |
Why?
|
| Patient Handoff | 1 | 2016 | 23 | 0.120 |
Why?
|
| Chylothorax | 1 | 2016 | 26 | 0.120 |
Why?
|
| Age of Onset | 1 | 2018 | 595 | 0.120 |
Why?
|
| Adult | 9 | 2026 | 31121 | 0.120 |
Why?
|
| Wilms Tumor | 1 | 2017 | 117 | 0.120 |
Why?
|
| Workplace | 1 | 2017 | 82 | 0.120 |
Why?
|
| Wounds, Penetrating | 1 | 2016 | 137 | 0.120 |
Why?
|
| Mentoring | 1 | 2017 | 84 | 0.120 |
Why?
|
| Abbreviated Injury Scale | 1 | 2015 | 9 | 0.120 |
Why?
|
| Adrenocortical Carcinoma | 1 | 2015 | 11 | 0.120 |
Why?
|
| Mentors | 1 | 2017 | 168 | 0.120 |
Why?
|
| Adrenal Cortex Neoplasms | 1 | 2015 | 24 | 0.110 |
Why?
|
| Head Protective Devices | 1 | 2015 | 22 | 0.110 |
Why?
|
| Vascular Diseases | 1 | 2017 | 150 | 0.110 |
Why?
|
| Interprofessional Relations | 1 | 2016 | 149 | 0.110 |
Why?
|
| Clinical Competence | 2 | 2013 | 1063 | 0.110 |
Why?
|
| Device Removal | 1 | 2017 | 223 | 0.110 |
Why?
|
| Klippel-Trenaunay-Weber Syndrome | 1 | 2015 | 6 | 0.110 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 1374 | 0.110 |
Why?
|
| Bicycling | 1 | 2015 | 36 | 0.110 |
Why?
|
| Adrenalectomy | 1 | 2015 | 31 | 0.110 |
Why?
|
| Hypoalbuminemia | 1 | 2014 | 16 | 0.110 |
Why?
|
| Glasgow Coma Scale | 1 | 2015 | 204 | 0.110 |
Why?
|
| Risk Factors | 4 | 2024 | 10941 | 0.110 |
Why?
|
| Massachusetts | 1 | 2014 | 115 | 0.110 |
Why?
|
| Time Factors | 3 | 2024 | 6197 | 0.110 |
Why?
|
| Safety | 1 | 2015 | 214 | 0.110 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2016 | 215 | 0.110 |
Why?
|
| Ultrasonography, Interventional | 1 | 2016 | 205 | 0.110 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2015 | 66 | 0.110 |
Why?
|
| Leukocyte Count | 1 | 2014 | 247 | 0.110 |
Why?
|
| Insurance, Health | 1 | 2015 | 140 | 0.100 |
Why?
|
| Bleomycin | 1 | 2014 | 116 | 0.100 |
Why?
|
| Physicians | 2 | 2017 | 634 | 0.100 |
Why?
|
| Kidney | 1 | 2020 | 1277 | 0.100 |
Why?
|
| Organometallic Compounds | 1 | 2014 | 110 | 0.100 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2014 | 122 | 0.100 |
Why?
|
| Antibiotic Prophylaxis | 2 | 2024 | 114 | 0.100 |
Why?
|
| Blood Transfusion | 1 | 2015 | 289 | 0.100 |
Why?
|
| Amniotic Fluid | 1 | 2014 | 146 | 0.100 |
Why?
|
| Gadolinium | 1 | 2014 | 108 | 0.100 |
Why?
|
| Ampulla of Vater | 1 | 2013 | 15 | 0.100 |
Why?
|
| Common Bile Duct Neoplasms | 1 | 2013 | 10 | 0.100 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2015 | 336 | 0.100 |
Why?
|
| Monitoring, Physiologic | 1 | 2015 | 369 | 0.100 |
Why?
|
| Biliary Tract Surgical Procedures | 1 | 2013 | 22 | 0.100 |
Why?
|
| Predictive Value of Tests | 2 | 2016 | 2293 | 0.100 |
Why?
|
| Medicaid | 1 | 2015 | 251 | 0.090 |
Why?
|
| Cloaca | 2 | 2024 | 13 | 0.090 |
Why?
|
| Body Weight | 1 | 2016 | 984 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 1288 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 1 | 2024 | 2562 | 0.090 |
Why?
|
| Urogenital Abnormalities | 2 | 2024 | 158 | 0.090 |
Why?
|
| Health Status Disparities | 1 | 2015 | 277 | 0.090 |
Why?
|
| SELEX Aptamer Technique | 1 | 2011 | 5 | 0.090 |
Why?
|
| Surgical Wound Infection | 2 | 2024 | 265 | 0.090 |
Why?
|
| Syndrome | 2 | 2024 | 1159 | 0.080 |
Why?
|
| Aged | 5 | 2016 | 20859 | 0.080 |
Why?
|
| Schools, Medical | 1 | 2012 | 116 | 0.080 |
Why?
|
| Patient Transfer | 1 | 2012 | 109 | 0.080 |
Why?
|
| Endoscopy | 1 | 2013 | 267 | 0.080 |
Why?
|
| Anemia | 1 | 2014 | 351 | 0.080 |
Why?
|
| Spinal Dysraphism | 1 | 2014 | 277 | 0.080 |
Why?
|
| Educational Measurement | 1 | 2013 | 316 | 0.080 |
Why?
|
| Contrast Media | 1 | 2014 | 479 | 0.080 |
Why?
|
| Comorbidity | 1 | 2015 | 1584 | 0.080 |
Why?
|
| DNA | 1 | 2015 | 1400 | 0.080 |
Why?
|
| Middle Aged | 5 | 2016 | 28366 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2016 | 2062 | 0.070 |
Why?
|
| Molecular Targeted Therapy | 1 | 2011 | 383 | 0.070 |
Why?
|
| Emergency Service, Hospital | 1 | 2016 | 1216 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 3031 | 0.060 |
Why?
|
| Combined Modality Therapy | 2 | 2024 | 1217 | 0.060 |
Why?
|
| Cohort Studies | 1 | 2015 | 5047 | 0.060 |
Why?
|
| Clinical Protocols | 1 | 2026 | 230 | 0.060 |
Why?
|
| Academic Medical Centers | 1 | 2026 | 319 | 0.050 |
Why?
|
| Lumbosacral Region | 1 | 2024 | 22 | 0.050 |
Why?
|
| Anal Canal | 1 | 2024 | 86 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2026 | 6438 | 0.050 |
Why?
|
| Rectum | 1 | 2024 | 101 | 0.050 |
Why?
|
| Hernia, Umbilical | 1 | 2024 | 42 | 0.050 |
Why?
|
| Neck | 1 | 2024 | 140 | 0.050 |
Why?
|
| Chest Tubes | 1 | 2023 | 38 | 0.050 |
Why?
|
| Spine | 1 | 2024 | 151 | 0.050 |
Why?
|
| Biological Factors | 1 | 2023 | 26 | 0.050 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2023 | 51 | 0.050 |
Why?
|
| Quality Improvement | 2 | 2023 | 706 | 0.050 |
Why?
|
| Postoperative Care | 1 | 2024 | 294 | 0.050 |
Why?
|
| Thoracotomy | 1 | 2023 | 107 | 0.050 |
Why?
|
| Public Opinion | 1 | 2023 | 63 | 0.050 |
Why?
|
| Sex Factors | 1 | 2026 | 1339 | 0.050 |
Why?
|
| Scoliosis | 1 | 2024 | 152 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 298 | 0.050 |
Why?
|
| Evidence-Based Practice | 1 | 2023 | 115 | 0.050 |
Why?
|
| Surgical Procedures, Operative | 1 | 2024 | 223 | 0.040 |
Why?
|
| Delivery, Obstetric | 1 | 2024 | 259 | 0.040 |
Why?
|
| Mutation | 1 | 2015 | 6094 | 0.040 |
Why?
|
| Lymphatic System | 1 | 2020 | 18 | 0.040 |
Why?
|
| Length of Stay | 1 | 2026 | 1398 | 0.040 |
Why?
|
| Empathy | 1 | 2021 | 69 | 0.040 |
Why?
|
| Pelvic Floor | 1 | 2020 | 36 | 0.040 |
Why?
|
| Infant, Premature | 1 | 2026 | 857 | 0.040 |
Why?
|
| Appendectomy | 1 | 2020 | 88 | 0.040 |
Why?
|
| Cysts | 1 | 2020 | 83 | 0.040 |
Why?
|
| Patient Safety | 2 | 2016 | 444 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2024 | 602 | 0.040 |
Why?
|
| Adoption | 1 | 2019 | 18 | 0.040 |
Why?
|
| Program Development | 1 | 2020 | 181 | 0.040 |
Why?
|
| Intestinal Volvulus | 1 | 2019 | 41 | 0.040 |
Why?
|
| Digestive System Abnormalities | 1 | 2019 | 38 | 0.040 |
Why?
|
| Recurrence | 1 | 2023 | 1470 | 0.040 |
Why?
|
| Policy Making | 1 | 2019 | 60 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2024 | 3753 | 0.040 |
Why?
|
| Eating | 1 | 2020 | 375 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2019 | 331 | 0.030 |
Why?
|
| Colon | 1 | 2021 | 363 | 0.030 |
Why?
|
| Breast Feeding | 1 | 2019 | 234 | 0.030 |
Why?
|
| Feces | 1 | 2021 | 720 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2021 | 525 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2019 | 443 | 0.030 |
Why?
|
| Lymphangiectasis | 1 | 2016 | 2 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 2896 | 0.030 |
Why?
|
| Bronchitis | 1 | 2016 | 29 | 0.030 |
Why?
|
| Punctures | 1 | 2016 | 51 | 0.030 |
Why?
|
| Intestinal Perforation | 1 | 2016 | 50 | 0.030 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2017 | 192 | 0.030 |
Why?
|
| Observer Variation | 1 | 2016 | 309 | 0.030 |
Why?
|
| Iatrogenic Disease | 1 | 2016 | 118 | 0.030 |
Why?
|
| Triage | 1 | 2016 | 143 | 0.030 |
Why?
|
| Selection Bias | 1 | 2015 | 17 | 0.030 |
Why?
|
| Intestines | 1 | 2019 | 587 | 0.030 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2015 | 28 | 0.030 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 1 | 2015 | 33 | 0.030 |
Why?
|
| Mediastinal Neoplasms | 1 | 2015 | 36 | 0.030 |
Why?
|
| Birth Weight | 1 | 2016 | 345 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 1160 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2015 | 155 | 0.030 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2015 | 77 | 0.030 |
Why?
|
| Accidents, Traffic | 1 | 2015 | 105 | 0.030 |
Why?
|
| Transplantation, Autologous | 1 | 2015 | 255 | 0.030 |
Why?
|
| Cholestasis | 1 | 2016 | 170 | 0.030 |
Why?
|
| Health Surveys | 1 | 2015 | 255 | 0.030 |
Why?
|
| Phenotype | 1 | 2024 | 4471 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 1877 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 625 | 0.030 |
Why?
|
| Radiography, Thoracic | 1 | 2014 | 145 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 2014 | 220 | 0.020 |
Why?
|
| Learning | 1 | 2017 | 368 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2016 | 811 | 0.020 |
Why?
|
| Neural Stem Cells | 1 | 2014 | 130 | 0.020 |
Why?
|
| Transplantation Conditioning | 1 | 2015 | 326 | 0.020 |
Why?
|
| Risk | 1 | 2015 | 722 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 708 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2015 | 402 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2016 | 396 | 0.020 |
Why?
|
| North Carolina | 1 | 2012 | 40 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2015 | 1210 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 1104 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 1456 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 1390 | 0.020 |
Why?
|
| Exercise | 1 | 2017 | 863 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 589 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2016 | 704 | 0.020 |
Why?
|
| Workload | 1 | 2012 | 149 | 0.020 |
Why?
|
| Continuity of Patient Care | 1 | 2012 | 143 | 0.020 |
Why?
|
| Logistic Models | 1 | 2015 | 1799 | 0.020 |
Why?
|
| Swine | 1 | 2014 | 1185 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2017 | 3362 | 0.020 |
Why?
|
| Prenatal Diagnosis | 1 | 2014 | 615 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 887 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2014 | 1449 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 2828 | 0.020 |
Why?
|
| Young Adult | 1 | 2023 | 9988 | 0.020 |
Why?
|
| Rats | 1 | 2014 | 3368 | 0.020 |
Why?
|
| Communication | 1 | 2012 | 539 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 1313 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2015 | 1271 | 0.010 |
Why?
|
| Prognosis | 1 | 2015 | 4859 | 0.010 |
Why?
|
| Animals | 2 | 2014 | 33796 | 0.010 |
Why?
|